IL6 and diabetes mellitus: It is not clear if these data are readily applicable to chronic forms of hyperglycemia such as types 1 and 2 diabetes but an ongoing clinical trial with a monoclonal antibody against IL‐6 in type 1 diabetes (NCT02293837) may be informative.